Life insurance owned by your corporation is the most misunderstood tool in corporate planning: sold too hard by people paid to sell it, dismissed too fast by people who have only seen it sold badly. Both camps skip the mechanics. This guide walks through them: where the money comes from, how the policy is taxed while you are alive, what happens at death, and the specific ways the structure goes wrong. By the end you should be able to tell whether it belongs in your corporation's plan, and roughly how large a role it deserves.
Everything here assumes an incorporated professional in Ontario at 2026 rates, and a corporation with genuine long-term surplus. If your corporation spends everything it earns, this page is not for you yet; the retained earnings problem comes first.
Why hold life insurance inside the corporation at all
The direct answer: because the corporation buys the same coverage with much cheaper dollars. A premium paid from small-business-rate profits costs the corporation about half of what the identical premium costs you personally at the top marginal rate.
The arithmetic is short. To fund a $10,000 annual premium personally at Ontario's top 53.53 percent marginal rate, you need about $21,500 of pre-tax income: earn it, pay tax, pay the premium with what is left. To fund the same premium with corporate dollars taxed at Ontario's 11.2 percent small business rate, the corporation needs about $11,300 of pre-tax profit. Same policy, same coverage, roughly $10,000 a year less pre-tax income consumed, every year the policy is in force.
Two qualifiers on the 11.2 percent. It applies to taxation years falling entirely after June 30, 2026; a corporate year that straddles that date blends to roughly 11.7 percent. And it assumes the corporation still has small business deduction room: a corporation whose limit has been ground away by passive income funds premiums with 17.2 percent dollars instead, which narrows the gap without closing it, and is itself one more reason to manage the grind.
That funding gap is the foundation, but it is not the whole case, and on its own it would not justify permanent insurance. The case gets its real weight from what happens to the money inside the policy and at death, which is where the next sections go. And one caution up front: the cheap-dollars argument applies to insurance you actually need. Buying unneeded coverage with cheap dollars is still buying something you did not need.
The structure: owner, payer, beneficiary
The direct answer: the standard clean structure makes the corporation the owner, the premium payer, and the beneficiary. It is not the only configuration the law permits, but mismatches invite shareholder benefit arguments, and those are the most expensive routine mistake in corporate insurance.
When the corporation pays premiums on a policy it owns and is the beneficiary of, the arrangement is clean: a corporate asset, bought with corporate dollars, paying proceeds to the corporation. Other configurations carry exposure that is fact-specific in size but predictable in kind. If the corporation pays premiums on a policy you own personally, the premiums are ordinarily a taxable benefit to you under subsection 15(1), with no offsetting deduction to the corporation: taxed twice, deducted never. If the corporation owns and pays but a shareholder's family or estate is named beneficiary directly, CRA can assess a shareholder benefit, measured by the premiums or potentially the proceeds depending on the facts. Whether and how much is arguable is exactly the problem: the mismatch converts a settled structure into a dispute with CRA, litigated at the worst possible moment.
The clean route to family is indirect but efficient: proceeds land in the corporation tax-free, and the capital dividend mechanism below moves them out to the estate or surviving shareholders largely tax-free. Resist the intuition that naming family directly is simpler; here, simpler is the trap.
Premiums are almost never deductible, and it mostly does not matter
The direct answer: corporate life insurance premiums are a non-deductible expense, with one narrow exception for policies assigned as loan collateral, and the economics survive the non-deductibility comfortably.
The exception first, because it is oversold, and its conditions are specific. Paragraph 20(1)(e.2) allows a deduction only where the policy is assigned as collateral to a restricted financial institution (a bank or similar regulated lender), the lender requires the assignment as a condition of the borrowing, and the interest on the borrowing is itself deductible. Even then the deduction is capped at the lesser of the premiums and the policy's net cost of pure insurance (NCPI), the actuarial cost of the raw death coverage, and prorated to the amount owing on the loan. Early in a permanent policy the NCPI is a small fraction of the premium, so a qualifying deduction is modest. Treat any pitch built on premium deductibility with suspicion.
Why non-deductibility does not sink the strategy: the comparison that matters is never premium versus deduction, it is corporate-dollar funding versus personal-dollar funding of coverage you need anyway, plus the tax treatment of the growth and the death benefit. Those three advantages are intact regardless.
Exempt growth, and the passive income connection
The direct answer: growth inside an exempt life insurance policy is not taxed annually and does not count toward adjusted aggregate investment income, which makes the policy one of the few places corporate surplus can compound without feeding the 50.17 percent passive tax rate or the small business deduction grind.
(Disclosure: insurance is part of how my practice is compensated. This section is the commercial heart of the strategy, so read it with that in mind, and hold it to the same test as everything else here: the mechanics have to work on their own numbers.)
Corporate surplus in GICs and bonds generates interest taxed at 50.17 percent as it is earned. Canadian portfolio dividends are taxed differently, a fully refundable Part IV tax of 38.33 percent, but they count toward AAII all the same when they come from non-connected corporations. Either way, the income feeds AAII, the number that grinds down the small business deduction once it passes $50,000. The full mechanics are in the guide to corporate investing and the passive income rules, and what counts as passive income covers the definitions.
An exempt policy sits outside that machinery. Money that goes in as premium and compounds as cash value is not taxed annually and adds nothing to AAII. In the worked comparison in five ways to manage the SBD grind, repositioning assets that had produced roughly $50,000 of annual AAII cut the example practice's AAII from $100,000 to $50,000, restoring its small business limit from $250,000 to the full $500,000 and saving $15,000 a year. "Exempt" is a defined status under Regulation 306: the policy's accumulation must stay within limits tested against a reference policy, which is the carrier's job to design and monitor, but it is why you cannot simply stuff unlimited surplus into a small policy.
The honest boundary: this only makes sense for surplus with a long horizon and an insurance need attached. The policy is not a savings account, and the early years prove it, as the cost section below shows.
The capital dividend account: how the death benefit exits tax-free
The direct answer: at death the corporation receives the benefit tax-free, and the death benefit minus the policy's adjusted cost basis credits the capital dividend account, from which tax-free capital dividends can be paid to shareholders or the estate.
This is the mechanism that answers the standard objection to corporate insurance, "the money gets trapped in the corporation." Without planning, extracting corporate wealth means taxable dividends at up to 47.74 percent personally. The CDA is the exception: a notional account defined in subsection 89(1) whose balance can be paid out with zero personal tax by election.
A worked example. A corporation owns a policy with a $2,000,000 death benefit. At death, the policy's adjusted cost basis, the ACB, is $150,000. The corporation receives $2,000,000 tax-free, and $1,850,000 credits the CDA. The estate can receive $1,850,000 as tax-free capital dividends; the remaining $150,000 simply stays ordinary corporate surplus, taxable as a regular dividend if and when it is distributed.
The ACB matters and moves. It rises in the policy's early years, roughly premiums in, minus the NCPI, and then declines as the cumulative NCPI grows; on many permanent policies it reaches or approaches zero at older ages, and where a given policy's curve sits is printed in its illustration. Die early and the CDA credit is the death benefit less a meaningful ACB; die late and the credit is often the full benefit. This curve is not a flaw; it is a schedule, and good planning knows where on the curve the policy sits.
You can run this section's arithmetic on your own corporation with the estimator below: the balance your realized gains and losses have built, and what a policy would add at death. Its output is a planning estimate to verify with your accountant, never a filing figure.
The two routes to the estate, side by side
The direct answer: the same corporate wealth reaches the estate dramatically differently depending on whether it travels as a taxable portfolio or as a death benefit through the CDA.
An illustrative comparison, deliberately simplified. Suppose the corporation holds $2,000,000 for the estate, either as an investment portfolio or as the death benefit of the policy above (ACB $150,000 at death):
| Corporate portfolio | Corporately owned policy |
|---|
| Corporation receives at death | $2,000,000 (already there) | $2,000,000 tax-free |
| CDA credit created | only whatever untaxed gain halves the portfolio itself has banked | $1,850,000 |
| Exits tax-free by capital dividend | that banked portion only | $1,850,000 |
| Taxed on the way out | the rest, through taxable dividends and dispositions | only the remaining $150,000, when distributed |
What the portfolio route actually loses is not reducible to one number: it depends on the portfolio's cost base and unrealized gains, its accumulated CDA, GRIP and RDTOH balances, the shareholder's own share ACB, and the post-mortem planning the estate runs (loss carrybacks, pipeline strategies). Any article that hands you a single dollar figure for that column is guessing, and a fair comparison also accounts for the premiums having left the portfolio over the years. What the table does establish is structural: the policy route's tax-free share is determined mechanically at death, proceeds minus the then-current ACB, while the portfolio route's tax-free share has to be assembled from whatever facts and planning exist after the fact. Run the long-horizon version on your own assumptions with the PAR versus real estate tool.
Participating whole life, in plain terms
The direct answer: PAR whole life is permanent coverage plus participation in the insurer's smoothed, conservatively managed participating account (not a distinct investment account you own): guaranteed premiums, guaranteed cash value, and non-guaranteed annual dividends that buy additional paid-up coverage and compound.
Participating whole life is the design most commonly proposed for corporate ownership in Canada (universal life is the main alternative, and works differently enough to deserve its own analysis), so this guide covers PAR specifically. The structure has four moving parts. The contractual premium is fixed and guaranteed. The guaranteed cash value grows on a schedule printed in the contract. The policy participates in the carrier's PAR account, a large, conservatively managed pool, and each year the carrier credits a dividend based on the account's smoothed performance. And by default those dividends buy paid-up additions: small, fully paid slices of extra coverage that carry their own cash value and earn their own future dividends, which is where the compounding comes from.
Two honesty requirements when you evaluate any illustration. Dividends are not guaranteed: the dividend scale moves with the PAR account's long-run returns, and an illustration is a projection, not a promise, so always read the reduced-scale columns. And early cash values are deliberately back-loaded: in the first several years the cash value is less than the premiums paid. This is a decades-long instrument. The PAR versus real estate comparison tool lets you test a PAR illustration against an alternative investment on your own assumptions.
Term insurance inside the corporation
The direct answer: for temporary, large needs, corporately owned term is the right tool, bought with the same cheap corporate dollars, and it converts to permanent coverage later if the permanent case matures.
Not every corporate insurance need is permanent. A practice loan, a young family, a buy-sell obligation with a fixed horizon: these call for large coverage at minimal cost, which is term. The corporate-dollar funding advantage applies just as well, the structure rules (corporation as owner, payer, beneficiary) apply identically, and the CDA mechanics work for term too: if the insured dies while covered, the death benefit less the policy's ACB, which for term is typically small, credits the CDA exactly as a permanent policy's would. What term lacks is cash value and the exempt accumulation, not the tax-free exit. A common and sensible sequence for a professional in their forties: substantial corporate term now, which may be convertible in tranches into PAR under the policy's contract and age limits as surplus accumulates and the estate case firms up. Conversion is a privilege the contract grants, not an automatic feature, so check the deadline in the actual policy before building a plan on it.
Uses while you are alive
The direct answer: beyond the estate mechanics, a corporately owned policy funds key person protection and buy-sell agreements, and its cash value can serve as collateral for corporate borrowing.
Three living uses recur in practice. Key person coverage replaces revenue while a practice recovers from the loss of the person who generates it, and for most incorporated professionals the key person is the shareholder. Buy-sell funding gives surviving shareholders or a successor the cash to buy out an estate, with the CDA mechanics improving the after-tax result. And an established policy's cash value is bankable collateral: lenders will lend against it, which in a more aggressive form is the basis of the immediate financing arrangement, a strategy with its own guide coming in this series. If a lender is involved, that is also where the 20(1)(e.2) deduction above can apply.
What it costs, and how you get out
The direct answer: the costs are early illiquidity, a multi-decade premium commitment, and exit routes that are all worse than staying the course, which is why sizing the commitment correctly at the start matters more than anything else on this page.
Surrendering a permanent policy in its early years returns less than was paid in, and any cash value above the ACB is taxed as ordinary income under section 148, not as a capital gain. Stopping premiums usually forces a choice between reduced paid-up coverage (smaller, but no further premiums) and letting dividends carry the premium if the policy is mature enough. Policy loans and partial withdrawals are available but carry their own tax rules: a partial withdrawal is a disposition that uses a prorated share of the ACB under subsection 148(4), not the whole ACB, and policy loans follow separate rules again, so neither is a casual source of cash. None of these are disasters; all of them are worse than having sized the policy to a premium the corporation can sustain through a bad year. The standard sizing error is committing the maximum illustrated premium in a good year. The standard fix is committing well under it.
Sizing the premium
The direct answer: size the premium to the surplus your corporation would still have in a bad year, not to the surplus of a good one, and leave room for every other planning priority to stay funded.
A workable sequence: start from the corporation's durable annual surplus, what is reliably left after your compensation, tax, and practice reinvestment across the last three years, not the best of them. Fund the priorities with better liquidity first: compensation sufficient to max RRSP and TFSA room, any IPP funding, and the practice's own reserve. What remains after that is candidate premium. My working rule of thumb, and it is a rule of thumb, not a law: commit roughly half to two-thirds of it, which is the difference between a policy that survives a renovation, an associate departure, or a revenue dip and one that gets surrendered into section 148 income at the worst time. On $150,000 of durable annual surplus, that means a premium well under the $150,000 a maximum illustration will happily show.
Under-committing usually costs little: many PAR designs accept additional deposits later within contract and exempt-test limits, and coverage can be layered with new policies as surplus proves durable, though new layers depend on underwriting at the time, your insurability then, and pricing at your attained age. Over-committing is the expensive direction. Every exit ramp in the section above is worse than never having needed one.
Who should not do this
The direct answer: no corporate surplus, no insurance need, or no decade of horizon means no policy, whatever the tax math says.
The strategy needs three things at once: genuine long-term surplus the practice will not need, an actual insurance need (estate liquidity, income replacement, buy-sell, key person), and a horizon measured in decades. Missing the first, the premiums compete with the practice's own cash needs and the early-year illiquidity bites. Missing the second, you are buying an investment wrapped in mortality costs you did not need. Missing the third, the back-loaded values never get to run. A corporation still building its first few hundred thousand of surplus is usually better served by the ordering in five ways to manage the SBD grind: compensation design and registered room first, insurance when the surplus is durable.
The mistakes that undo everything
Five errors account for most of the damage in this area. Naming a personal beneficiary on a corporate policy, the 15(1) trap from the structure section. Believing an illustration's current dividend scale as if it were guaranteed. Buying the maximum premium instead of the sustainable one. Treating the policy as an emergency fund and surrendering early into section 148 income. And transferring a personal policy into the corporation casually, without valuing the disposition. Every one of these is avoidable at the design stage, and none is fully fixable afterward.
How this fits an incorporated professional's whole plan, corporate investments, compensation, and retirement structure included, is what I do: the practice pages for physicians and dentists describe the process. The numbers on this page are 2026 Ontario figures and the statutory mechanics current to the date above; both are re-verified on every review of this guide.
